Meeting Posters

A novel method for differentiating acute suicidal ideation and intent using multimodal digital biomarkers (Abstract)

Aafjes
2025 Autumn Conference – Includes Joint Day with ECNP

Using large language models for endpoint oversight (Abstract)

Kolar
2025 Autumn Conference – Includes Joint Day with ECNP

Challenges of central nervous system (CNS) drug development: Evaluation of European Medicines Agency (EMA) rejections and withdrawals by human and artificial intelligence raters (Abstract)

De Lillo
2025 Autumn Conference – Includes Joint Day with ECNP

Towards more reliable sleep scoring in CNS trials by way of artificial intelligence (Abstract)

Lagler
2025 Autumn Conference – Includes Joint Day with ECNP

Maximizing ROI in CNS trials: Using AI models to score 100% of CNS primary outcome interviews and enhance human clinical reviews (Abstract)

DeBonis
2025 Autumn Conference – Includes Joint Day with ECNP

Benchmarking commercial and open-source speech AI for speaker attribution in real-world clinical conversations (Abstract)

Bruzinski
2025 Autumn Conference – Includes Joint Day with ECNP

Feasibility of an AI-administered COA using a multi-agent framework (Abstract)

McLaughlin
2025 Autumn Conference – Includes Joint Day with ECNP

Leveraging ML-derived patient personas to assess functional unblinding in ketamine trials for major depressive disorder (Abstract)

Geraci
2025 Autumn Conference – Includes Joint Day with ECNP

Evaluating the validity of LLM-based psychological assessments: A comparative study using the Attributional Style Questionnaire (Abstract)

Mikus
2025 Autumn Conference – Includes Joint Day with ECNP

AI-enabled direct observation of participant medication adherence predicts early termination risk in clinical trials (Abstract)

Gross
2025 Autumn Conference – Includes Joint Day with ECNP

Retention unlocked: A tech-enabled operational monitoring and reporting framework to reduce early termination in clinical trials (Abstract)

Gross
2025 Autumn Conference – Includes Joint Day with ECNP

Clustering of medication adherence trajectories (Abstract)

Pironet
2025 Autumn Conference – Includes Joint Day with ECNP

Assessing recruitment funnel performance: A comparative analysis of digital advertising and HCP referrals in Alzheimer’s trials (Abstract)

Belleface
2025 Autumn Conference – Includes Joint Day with ECNP

Do we fully capture patient experiences? Incorporating patient and caregiver voices to define clinical meaningfulness in neurodegenerative trials (Abstract)

Anand
2025 Autumn Conference – Includes Joint Day with ECNP

Factors influencing adherence in a remote observational study with multiple immunology and neurology disease cohorts (Abstract)

Taptiklis
2025 Autumn Conference – Includes Joint Day with ECNP

Combining digital therapeutics with neuroplasticity-inducing agents: A framework modeled on MAT (Abstract)

Murck
2025 Autumn Conference – Includes Joint Day with ECNP

A dual-table framework for rigorous definition of integrated interventions in CNS trials (Abstract)

Price
2025 Autumn Conference – Includes Joint Day with ECNP

Adapting bridging study methodology for prescription digital therapeutics: A case study in migraine prevention with CT-132 (Abstract)

Snipes
2025 Autumn Conference – Includes Joint Day with ECNP

Cognitive variability as a design consideration in cognitive impairment associated with schizophrenia (CIAS) treatment trials (Abstract)

Harvey
2025 Autumn Conference – Includes Joint Day with ECNP

Cognitive safety assessment in a randomized, double-blind, phase 2 RSV clinical trial in adults over 60 years of age (Abstract)

Stravoravdi
2025 Autumn Conference – Includes Joint Day with ECNP